Moconasal Spray (Mometasone Furoate)

Adult dosage

For allergic rhinitis: Spray twice in each nostril, once daily (total daily dose of 0.2 mg). If symptoms improve, the frequency can be reduced to once daily (total daily dose of 0.1 mg) in each nostril. Up to four sprays can be administered in each nostril once daily (total daily dose of 0.4 mg). For nasal polyps: Spray twice in each nostril, once daily (total daily dose of 0.2 mg). If symptoms persist, further adjustments.

Children's dosage

For allergic rhinitis: Children aged 2 to 11 years should spray once in each nostril, once daily (total daily dose of 0.1 mg).

This medication should not be used by patients with a known allergy or history of hypersensitivity to this medication or any of its components. It should also not be used by patients with untreated infections of the nasal mucosa, those who have recently undergone nasal surgery, or who have wounds in the nasal area. Specifically, it should not be administered to infants under the age of 2. Caution is advised in cases of respiratory tuberculosis, systemic fungal infections, viral infections, and in patients with herpes simplex in the eyes. Patients with recurrent nosebleeds or those at risk of exposure to chickenpox or measles should take special care. Pregnant or breastfeeding women should consult a physician regarding the use of this medication. Side effects such as headache, nosebleed, coughing, and upper respiratory infections may occur with the use of this medication, and occasionally serious reactions such as allergic reactions or anaphylaxis can occur, requiring immediate cessation of use and consultation with healthcare professionals if symptoms arise. Prolonged use at high doses may lead to systemic side effects, so dosage and duration should be strictly adhered to. Local nasal infections may develop while using this medication, so if symptoms of infection appear in the nasal cavity or pharynx, use should be discontinued, and treatment should be initiated. Patients at risk of infection with chickenpox or measles should check their history and vaccination status before using this medication, and inform medical personnel immediately if infected. In pediatric patients, growth delays may occur, so regular monitoring of growth is necessary, and it is important to treat at the minimum effective dose. Elderly patients may experience impaired bodily functions, requiring careful administration while monitoring their condition closely. Special treatment is generally not needed for overdose, but the potential for side effects due to corticosteroid overdose should be considered. Before use, shake the container well, perform a few test sprays and ensure that it is only used for intranasal spraying without direct application to the eyes or nasal septum. This medication must be stored out of reach of children and there are no reported effects on driving or operating machinery.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and very severe headache, thunderclap headache, seizures, confusion, vision changes, paralysis.

Mild side effects

• Headache
• viral infections
• pharyngitis
• nosebleed
• coughing
• upper respiratory infection
• menstrual pain
• musculoskeletal pain
• sinusitis
• vomiting

This medication should be stored in a tightly sealed container to prevent air or moisture ingress, preferably in a cool place between 2 and 25 degrees Celsius.

Appearance

A translucent white liquid in a plastic container that emits a certain amount with each spray.

Package unit

18 grams/bottle